Sari, I.K. (2025) “Preclinical Evaluation of HPV Type 52 L1L2 Chimeric Protein as a Cervical Cancer Vaccine Candidate”, HAYATI Journal of Biosciences, 33(3), pp. 556–565. doi:10.4308/hjb.33.3.556-565.